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Abstract
Clostridium difficile is a major cause of infectious diarrhea worldwide. Although the cell surface proteins are
recognized to be important in clostridial pathogenesis, biological functions of only a few are known. Also, apart from
the toxins, proteins exported by C. difficile into the extracellular milieu have been poorly studied. In order to identify
novel extracellular factors of C. difficile, we analyzed bacterial culture supernatants prepared from clinical isolates,
630 and R20291, using liquid chromatography-tandem mass spectrometry. The majority of the proteins identified
were non-canonical extracellular proteins. These could be largely classified into proteins associated to the cell wall
(including CWPs and extracellular hydrolases), transporters and flagellar proteins. Seven unknown hypothetical
proteins were also identified. One of these proteins, CD630_28300, shared sequence similarity with the anthrax
lethal factor, a known zinc metallopeptidase. We demonstrated that CD630_28300 (named Zmp1) binds zinc and is
able to cleave fibronectin and fibrinogen in vitro in a zinc-dependent manner. Using site-directed mutagenesis, we
identified residues important in zinc binding and enzymatic activity. Furthermore, we demonstrated that Zmp1
destabilizes the fibronectin network produced by human fibroblasts. Thus, by analyzing the exoproteome of C.
difficile, we identified a novel extracellular metalloprotease that may be important in key steps of clostridial
pathogenesis.
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Introduction
Clostridium difficile, a Gram-positive, spore-forming,
anaerobic bacterium, is one of the main causes of antibiotic-
associated diarrhea worldwide. The clinical outcomes, which
are generally referred to as C. difficile associated disease
(CDAD), range from mild diarrhea to more severe conditions
such as pseudomembranous colitis and toxic megacolon [1,2].
In the last decade, new epidemic strains belonging to the BI/
NAP1/027 category have emerged, causing an increase in
rates and severity of CDAD in North America and Europe [3,4].
Recurrent infections and an increase in antibiotic-resistant
strains have made treatment of C. difficile infections extremely
difficult [5].
The two glucosyltransferase toxins, toxin A and toxin B, are
crucial virulence factors of C. difficile [6,7]. Following
internalization by the gut epithelial cells, these toxins are able
to inactivate Rho family GTPases, leading to disruption of the
actin cytoskeleton and death of colonocytes, with dramatic
consequences on the function of the intestinal epithelial barrier
and establishment of a severe inflammatory response [8]. In
addition to toxin A and toxin B, a minority of strains produce a
binary toxin, also called C. difficile transferase (CDT), that
ADP-ribosylates actin, causing disruption of the host cell
cytoskeleton [9].
Apart from toxins, other factors are important for the
establishment of the bacterium in the gut and the development
of pathogenesis. It has been shown that some surface proteins
of C. difficile influence interactions with the host and the
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outcome of infection. The fibronectin-binding protein Fbp68 is
important in adhesion and colonization of C. difficile [10].
Flagellar proteins have been reported to be involved in
adherence, although their functions during infection are not
clear [11,12] The high molecular weight (MW) surface layer
protein is involved in adherence of C. difficile to host cells [13],
while cell wall proteins (CWPs) Cwp66 and Cwp84 have been
shown to be important in adherence and degradation of
extracellular matrix respectively [14,15]. Also, it is likely that
during colonization of the gut C. difficile releases not only the
known toxins but also other proteins. However, there is little
information about proteins secreted by C. difficile into its
environment. A recent report described Srl, a protein found in
culture supernatants that modulates the cell sensitivity to toxins
A and B [16].
A systematic identification and functional characterization of
C. difficile secreted proteins that are exposed on the surface or
released in the environment, is central to understand the
mechanisms involved in C. difficile interactions with the host.
Proteomics have been previously employed effectively to
identify new pathogenic determinants in various pathogens and
to understand differences between various clinical strains
[17,18]. Although previous studies have tried to characterize
extracellular protein profiles of C. difficile [19-21], the precise
cellular localization of the proteins identified was unclear due to
the presence of cytoplasmic proteins. The goal of this work was
to employ proteomics to identify novel extracellular factors that
may be relevant in C. difficile pathogenesis. Here we describe
the identification of C. difficile extracellular proteins in bacterial
culture supernatants from two clinically relevant isolates using
liquid chromatography-tandem mass spectrometry (LC-MS/
MS). Moreover, from the analysis of C. difficile supernatants,
we identified and characterized a novel zinc-dependent
metalloprotease, Zmp1, which is able to degrade fibrinogen
and fibronectin in vitro.
Materials and Methods
Bacterial strains and culture conditions
C. difficile clinical isolates 630 and R20291 were used in this
study. Bacteria were grown in liquid or solid media at 37°C
under anaerobic conditions (80% N2, 10% CO2, 10% H2) in a
Don Whitley workstation (Yorkshire, UK).
For proteomic analysis, bacteria were cultured in chemically
defined minimal medium (CDMM), prepared as described
previously [22]. Bacteria from glycerol stocks were grown O/N
on solid BHI (brain heart infusion) medium supplemented with
5 g/l yeast extract and 1 g/l cysteine. One single colony was
inoculated in 5 ml of CDMM and grown O/N to stationary
phase. The resulting culture was diluted in 5 ml of the same
medium to a starting OD600 of 0.05 and grown to mid-
exponential phase (0.4-0.8). The culture was diluted again to a
starting OD600 of 0.05 in 50 ml of the same medium, grown up
to mid-exponential phase (0.4-0.8) and used for subsequent
sample preparation for mass spectrometry (MS).
Sample preparation for MS/MS analysis
To analyze the protein content of culture supernatants, after
reaching the desired phase of growth, cultures were
centrifuged at 3,200 g for 10 min. The supernatant was filtered
through a 0.22 µm filter to remove any remaining bacteria, and
EDTA-free Complete protease inhibitor cocktail (Roche, NJ,
USA) and 5 mM EDTA were added. Proteins were precipitated
by 10% TCA (trichloroacetic acid) (v/v), 0.04% sodium
deoxycholate (w/v) incubating for 3 h on ice, followed by
centrifugation at 37,000 g for 20 min. The pellet was
resuspended in 10% TCA and centrifuged as before. Pellets
were washed three times with decreasing amounts of cold
absolute ethanol (half volume, 1 ml, 200 µl), then dried in a
vacuum concentrator and suspended in 50 mM ammonium
bicarbonate.
Proteins recovered from the pellet were denatured by 0.1%
Rapigest® (w/v) (WatersTM, MA, USA) and 5 mM DTT and
boiled for 10 min. After cooling, the pH was adjusted to 7.8- 8.5
using ammonium bicarbonate. 1µg of trypsin was added and
the digestion reaction was incubated O/N at 37°C. Digested
samples were cleaned using OASIS Cartridges HLB
(WatersTM) for LC-MS/MS analysis.
Protein identification by nano-LC-MS/MS
Peptides were separated by nano-LC on a NanoAcquity
UPLC system (WatersTM) connected to a Q-ToF Premier
Electro Spray Ionization (ESI) mass spectrometer equipped
with a nanospray source (WatersTM).  Samples were run as
previously described [23]. Protein identification was achieved
using MASCOT (version 2.2.1) by searching in a locally
curated database combining protein sequence data derived
from the Clostridium difficile section of the NCBInr database,
the total number of sequences and residues being 57,275 and
17,440,799, respectively. The score thresholds for acceptance
of peptide identification were ≥48 for trypsin digestion, as
defined by the MASCOT scoring.
Preparation of C. difficile and culture supernatant
fractions and immunoblotting
To prepare a total cell extract, strain 630 was grown in
Trypticase Yeast extract Mannitol (TYM) to OD600 1.3
(exponential phase in this medium). Cells were harvested by
centrifugation and the pellet was washed, resuspended in PBS
(phosphate buffered saline) and lysed by freeze-thawing. To
isolate the cell wall fraction, containing the S-layer proteins and
other proteins present within the cell wall, bacteria were grown
in 20 ml of TYM to OD600 1.3. Cells were collected by
centrifugation at 3,200 g, washed once in PBS and once in
Tris-sucrose buffer (10 mM Tris-HCl pH 6.9, 10 mM MgCl2, 0.5
M sucrose). The pellet was then incubated in 2 ml of digestion
buffer (Tris-sucrose buffer with 250 µg/ml mutanolysin and
protease inhibitors) for 2 h at 37°C with gentle agitation. The
reaction was centrifuged to separate the supernatant that
contains the cell wall fraction from the pellet that contains the
protoplast fraction. Protoplasts were resuspended in PBS and
lysed by freeze-thawing.
The S-layer fraction, containing only proteins associated to
the S-layer, was prepared as described previously [24] after
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growing bacteria in 50 ml of TYM broth to OD600 1.3. To
prepare supernatant fractions, bacteria of strain 630 were
grown in TYM to the exponential growth phase (OD600 1.3) and
centrifuged at 3,200 g to separate the culture supernatant (total
supernatant). The total supernatant was ultracentrifuged at
150,000 g for 16 h to obtain two fractions, ultracentrifugation
pellet (UP) and ultracentrifugation supernatant (US). To
prepare total supernatant and US fractions for immunoblot
analysis, proteins were precipitated by addition of TCA, as
described for LC-MS/MS analysis, and then resuspended in
PBS. The UP was immediately resuspended in PBS.
10 µl of different cellular preparations, concentrated with
respect to the culture volume, were analyzed by SDS-PAGE:
10X total extract, 20X protoplast, 10X mutanolysin extract,
100X S-layer extract and 10X supernatant fractions (total
supernatant, supernatant and pellet after ultracentrifugation)
were probed for CD630_01830, CD630_02370 (FliD) and
CD630_23650. 3 times more of each cell fraction and 25 times
more of each supernatant fraction were analyzed for
CD630_28300 (Zmp1). Samples were separated by SDS-
PAGE on a NuPAGE gel (Invitrogen) and transferred onto
nitrocellulose membranes for western blot analysis. The
membranes were blocked for 1 h with 10% milk in PBS, 0.05%
Tween-20 at RT. Primary antibodies used were polyclonal
murine antisera raised against recombinant His-tagged
CD630_01830, CD630_02370 (FliD), CD630_23650 and
CD630_28300 (Zmp1). All the primary antibodies used were
diluted 1:1000 and incubated with the membrane for 1.5 h at
37°C. The secondary antibody, goat anti-mouse serum
conjugated to horseradish peroxidase (1:5000; Dako), was
incubated at RT for 45 min. Super Signal Chemiluminescent
Substrate (Pierce) was used for detection of bound antibodies
following the manufacturer's instructions.
Cloning and site-directed mutagenesis of Zmp1
A modified version of pET15 (Novagen), pET15/TEV, was
constructed to express N-terminal His-tagged proteins. The
multiple cloning site of pET15 was replaced with a His-TEV-
ccdB-chloramphenicol cassette amplified from the SpeedET
vector using polymerase incomplete primer extension (PIPE).
The gene fragment encoding Zmp1, corresponding to
residues 27–220, was amplified by PCR from C. difficile 630
genomic DNA using primers Zmp1-F (5’-
CTGTACTTCCAGGGCGATAGTACTA
CTATACAACAAAATAAAG) and Zmp1-R (5’-
AATTAAGTCGCGTTATTTAGCTA AATTTTGCAAAAAGC).
The PCR fragment was cloned into the pET15-TEV vector
using the PIPE method (25) to obtain a protein lacking the
signal peptide and carrying a 6X His-tag at the N-terminus.
Site-directed mutagenesis using the PIPE system was
performed to generate the E143A mutant. Primers E143A-F
(5’- GAATTACATGCAACAGCACATGCAATAGACC) and
E143A-R (5’-GTGCTGTTGCATGTAATTCTAAATTTATTGC)
were used to substitute the GAA codon (glutamate) with the
GCA codon (alanine). Site-directed mutagenesis with the
GeneArt® Site-Directed Mutagenesis system (Invitrogen-Life





were used to substitute the CAT codon (histidine) with the GCT
codon (alanine).
Expression and purification of wild type and mutant
recombinant Zmp1
Protein expression was performed in T7 Express E. coli cells
(New England Biolabs). To produce the unlabeled His-tagged
Zmp1 wild type or mutants, the cells were cultured overnight at
30°C in EnPresso medium (Biosilta-Oulu, Finland) following the
manufacturer’s instructions. Protein expression was induced
with 1 mM IPTG for 8 h at 30°C. To produce 15N labeled
samples for NMR (nuclear magnetic resonance) studies, the
cells were grown at 37°C in M9 minimal medium containing 1
mg/ml of (15NH4)2SO4, until OD600 ~ 0.7 and then induced with 1
mM IPTG for 3 h at 37°C. The harvested cells were lysed by
sonication in binding buffer (20 mM Tris-HCl, 300 mM NaCl, 10
mM imidazole, pH 8.0) and centrifuged. The supernatant was
loaded onto a PD-10 gravity flow empty column (GE
Healthcare, NJ, USA) packed with 2 ml of Ni-NTA FF resin
(Qiagen GmbH, Hilden, Germany) equilibrated with the binding
buffer. The protein was eluted with buffer containing 300 mM
imidazole. Buffer was then exchanged in 50 mM Tris-HCl, 0.5
M EDTA, 1 mM DTT, pH 8.0 (TEV buffer) and cleavage of the
His-tag with the tobacco etch virus (TEV) protease (Invitrogen)
was carried out at RT O/N. After digestion, TEV buffer was
replaced with binding buffer and a second subtractive IMAC
purification was performed on the Ni-NTA column. The purified
tag-less protein, collected in the flow-through, was quantitated
using a BCA assay (Pierce, Rockford, IL, USA). The final purity
of the proteins was checked by SDS-PAGE. To obtain the
recombinant Zmp1 apo samples suitable for the activity assays
the protein was incubated in 50 mM sodium acetate, 20 mM
EDTA, pH 5.0, at 4°C O/N. The buffer was then exchanged
with Tris buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7.6) using
a PD-10 desalting column (GE Healthcare, NJ, USA). Different
metallated forms of Zmp1 were obtained by addition of ZnCl2,
CuCl2 or NiCl2 solutions up to the desired final concentration.
Production of recombinant proteins and antibodies
CD630_01830, FliD and CD630_23650 coding sequences
were amplified by PCR and cloned into pET15/TEV vector
using the PIPE method. Proteins lack the signal peptide and
contain a 6XHis-tag at the N-terminus. Protein expression was
performed in T7 Express E. coli cells (New England Biolabs) as
described above for Zmp1. Protein purification was performed
by one-step IMAC chromatography following the same protocol
already described for Zmp1. The final purity of the proteins was
checked by SDS-PAGE. Eight mice were immunized three
times with 10 µg of recombinant protein per dose. The resulting
sera were pooled and used in immunoblotting analysis.
Differential scanning fluorimetry (DSF)
The shifts in the melting temperature of Zmp1 wild type,
E143A and H146A as a function of Zn2+, Cu2+ or Ni2+
concentration were determined with DSF analysis, as
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described previously [25]. In each well, apo protein was
incubated at a concentration of 20 μM in 20 μl Tris buffer, in the
presence of ZnCl2, CuCl2 or NiCl2 in a final concentration
ranging from 0 to 0.5 mM. The plate was subjected to a
temperature gradient scan (25–95 °C) in a real time PCR
machine (Agilent Technologies, Santa Clara, CA, USA). The
fluorescence intensity was measured by use of fluorescence
Sypro Orange dye (5x final concentration) at different
temperatures with excitation and emission wavelengths of 490
and 575 nm, respectively.
NMR analysis
To obtain the recombinant Zmp1 apo samples the protein
was incubated in 50 mM sodium acetate, 20 mM EDTA, pH
5.0, at 4°C O/N. The buffer was exchanged in 20 mM HEPES,
pH 7.2 using a PD-10 desalting column (GE Healthcare, NJ,
USA) and the samples were concentrated up to 100 µM by
amiconultra-15 10kDa (GE). NMR experiments were acquired
at 298K on an Avance 900 Bruker spectrometer working at
900,13 MHz frequency and equipped with a cryogenically-
cooled probe. Zinc binding by apo proteins was assessed by
titrating the apo wild type, E143A and H146A Zmp1 proteins
with ZnCl2 solution (10 mM), directly in the NMR tube under N2
atmosphere in the presence of 1 mM DTT. The titration was
followed through 1H-15N HSQC NMR spectra.
In vitro proteolytic activity of Zmp1 on fibronectin and
fibrinogen
To test for cleavage of fibronectin, 1µM fibronectin from
human plasma (Sigma-Aldrich) was incubated at 37°C up to 24
h in Tris buffer in absence or presence Zmp1 (0.48-7.7 µM)
and in absence or presence of 0.5 mM ZnCl2, NiCl2 or CuCl2.
To test for cleavage of fibrinogen from human plasma, 1 µM
fibrinogen was incubated at 37°C up to 24 h in Tris buffer in
absence or presence µM Zmp1 (0.015-1 µM) and in absence
or presence of 0.5 mM ZnCl2. Reactions were analyzed by
separation on NuPAGE gels followed by staining with Problue
Safe stain (Giotto Biotech).
NH2-terminal sequence analysis of fibrinogen and
fibronectin fragments
Aliquots of fibrinogen and fibronectin samples incubated in
presence of Zmp1 24h at 37°C were subjected to SDS-PAGE
on 4-12% gels and transferred to polyvinylidene fluoride
membranes (iBlot® Transfer Stack- Life technologies). The
membranes were stained with 1% Ponceau S/ 1.0% acetic acid
and the band corresponding to the degraded fibrinogen beta
subunit fragment and 3 bands corresponding to degraded
fibronectin fragments were excised and sent to Alphalyse A/S
(Odense - Denmark) to be subjected directly to multiple cycles
of Edman degradation on ABI Procise 494 sequencer.
Proteolytic activity of Zmp1 protein on human
fibroblasts
IMR-90 cells (Human fibroblasts, ATCC) were maintained in
Eagle’s Minimum Essential Medium (EMEM, ATCC)
supplemented with 10% heat-inactivated fetal bovine serum
(FBS, Gibco) and antibiotics at 37°C in 5% CO2.
To study Zmp1 activity, cells were seeded on 8-well chamber
slides coated with collagen I (2.5 x 104 per well) (BD BioCoat)
and grown for 2 days. Cells were then incubated with 11.6 µM
of recombinant Zmp1 or mutant Zmp1 proteins and 0.1 mM
ZnCl2 for 16 h at 37°C in EMEM without FBS to avoid the
interference of plasma fibronectin. After washings, cells were
fixed with 3.7% paraformaldehyde. Samples were washed
extensively and incubated with rabbit anti-fibronectin antibodies
(Sigma-Aldrich) for 1 h at RT. After multiple washings, samples
were incubated with Alexa Fluor 568 goat anti-rabbit IgG. Glass
coverslips were mounted with ProLong® Gold antifade reagent
with DAPI and analyzed with a Zeiss LSM710 confocal
microscope.
For quantitation of fibronectin degradation, as before, IMR-90
cells (seeded equally at 2.5 x 104/well) were cultured on
chamber slides for 3 days, followed by incubation with 11.6 µM
of recombinant Zmp1 or mutant Zmp1 proteins and 0.1 mM
ZnCl2 for 16 h at 37°C in EMEM. After repeated pipetting, 100
µl cell culture supernatants were collected from each well and
probed with 1:1000 anti fibronectin (Sigma).
Results
Identification of extracellular proteins from Clostridium
difficile culture supernatants
In order to comprehensively identify proteins present in
extracellular milieu during C. difficile growth, we analyzed
culture supernatants prepared from two clinical C. difficile
strains, 630 and R20291, grown in chemically defined medium
(CDMM), using a shotgun proteomic approach. After bacterial
pellet removal, proteins present in the supernatant were
precipitated, digested with trypsin and analyzed by LC-MS/MS.
The proteins detected in the supernatant were derived only
from vegetative cells, as the percentage of spores present in
the growth culture was less than 0.01%.
Analysis of 630 and R20291 culture supernatants led to the
identification of a total of 58 unique proteins (6 biological
replicates for strain 630, and 3 biological replicates for strain
R20291) (Figure 1A and B, Figure S1). Among these, 25
proteins were identified from both strains, while 28 were
detected only in 630 and 5 only in R20291. All the genes
(except CD630_23880 and CDR20291_2278) encoding the
proteins detected in 630 and R20291 are present in both
strains, indicating that the lack of detection in one of the two
strains may be due to the fact that the protein is not expressed
or that it is expressed less under the conditions tested.
The identified proteins were classified into two main classes
depending on the predicted association to the cell wall (Figure
1A and B). The group comprising cell wall associated proteins
contains 24 proteins. Among these, 16 proteins have motifs
responsible for their association to C. difficile peptidoglycan,
which are either the cell wall binding repeat 2 domain
(pfam04122), characteristic of the family of cell wall proteins
(CWPs) [24,26] or a LPXTG-like motif that is thought to
mediate covalent attachment to the peptidoglycan by sortases,
as reported for other Gram-positive bacteria [27,28]. Among
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Figure 1.  Identification of extracellular proteins from Clostridium difficile culture supernatants.  (A) Family distribution of
putative surface/released proteins detected in 630 and R20291 culture supernatants. Proteins identified have been divided in
families based primarily on the presence of motifs for association to the peptidoglycan and secondly on the presence of conserved
functional domains. (B) Proteins detected by LC-MS/MS in C. difficile 630 and R20291 culture supernatants. Presence of a signal
peptide motif was predicted with SignalP 4.0 using the 630 amino acid sequence (except for CDR20291_2278, for which a
sequence with amino acid identity >40% is not present in 630). Cellular localization was predicted by PSORTb 3.0 using the 630
amino acid sequence (except for CDR20291_2278). Detection in 630 or R20291 culture supernatants is indicated by ‘yes/no’.
doi: 10.1371/journal.pone.0081306.g001
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the CWPs identified in the supernatant, the only ones which
have been previously described are CwpV [29], Cwp84 [15,30],
Cwp66 [14], Cwp2 [13,31], SlpA [24,32]. Remarkably, Cwp24
was identified in both 630 and R20291 supernatants, although
the corresponding gene has recently been annotated as a
pseudogene in the reference 630 genome [33]. The remaining
8 proteins are putative hydrolases likely involved in cell wall
metabolism, including the previously characterized autolysin
Acd [34].
The group of non-cell wall associated proteins comprises 34
proteins which can be further divided in the following 5 families:
transporters (8), flagellar components (10), hypothetical
proteins (7), other surface-predicted (4) and cytoplasmic
proteins (5) (Figure 1) Most of the identified transporters are
solute binding subunits of ABC transporters predicted to be
involved in the uptake of sugars, amino acids, peptides or
inorganic ions. For five of them, a putative lipobox motif was
predicted by DOLOP (http://www.mrc-lmb.cam.ac.uk/genomes/
dolop/analysis.shtml). Flagellar components were also a major
protein family detected in the culture supernatants. While the
major flagellar subunit (FliC) [35] was present in both strains,
other proteins predicted to be part of the basal body, hook and
cap structures were identified only in 630. It is possible that
R20291 flagella are less easily detached from the cell, as
compared with 630, or their components are less expressed in
the growth conditions tested in this study. Seven proteins
annotated as hypothetical were identified. Although cellular
localization could not be assigned for most of them by
bioinformatics with PSORTb (Figure 1B), a cleavage site for
signal peptidase could be predicted by SignalP for all of them
(Figure 1B). Our results highlight the importance of
experimental analyses to improve the performance of software
designed for protein localization prediction.
Only five cytoplasmic proteins were identified. Among these
proteins, EF-Tu, GAPDH and enolase have been very often
associated to the surface of Gram-positive bacteria [23,36].
With the exception of the EF-Tu (CD630_00580), which was
identified in 3 out of 9 experiments, all other cytoplasmic
proteins were identified in only one of the 9 experiments.
Moreover the number of peptides identified for each
cytoplasmic protein was no more than 2 (Figure S1). These
data indicate extremely low levels of bacterial cell lysis in the
samples analyzed. We did not detect the C. difficile toxins A
and B in the supernatants, as these toxins are not produced in
the conditions we used for our experiments, as described in
previous reports [21].
Thus, our data show the extracellular localization of different
classes of proteins in culture supernatants from C. difficile
strains. We also detect new extracellular unknown hypothetical
proteins that may have potential roles in C. difficile physiology
and pathogenesis.
Cellular localization of proteins identified by
proteomics
In order to clarify the subcellular localization of the proteins
found in 630 culture supernatants, antibodies against the
recombinant forms of 4 proteins representing different protein
classes, a cell wall associated LPXTG-like motif containing
protein (CD630_01830, MW-37 kDa), a transporter protein
(CD630_23650, MW-39kDa), a flagellar protein, FliD [37]
(CD630_02370, MW-58 kDa) and a hypothetical protein
(CD630_28300, MW-24 kDa), were generated in mice and
used to study the presence of the proteins in the culture
supernatants and in other cellular fractions by immunoblotting.
These studies were performed in a complex medium, TYM,
which may represent a more physiological condition.
In agreement with the proteomic data, the presence of the
four proteins in culture supernatants was confirmed. In order to
understand if the proteins were released in the supernatant as
high molecular weight structures, supernatants were subjected
to high-speed centrifugation. Both the ultracentrifugation pellet
(UP) and the corresponding ultracentrifugation supernatant
(US) were tested by immunoblotting analysis. The proteins
CD630_01830, CD630_23650 and CD630_28300 were found
in the US and not in the UP (Figure 2), indicating that these
proteins were not derived from any membranous or cell wall
fragments released from the cells. On the contrary, FliD was
also found in the UP, suggesting that entire flagellar structures
may be released into the medium. In accordance to the
bioinformatic predictions, CD630_01830 was found in the S-
layer (SL) and mutanolysin extract (ME) preparations, which
are expected to contain proteins associated with the cell wall,
while the putative lipoprotein CD630_23650 was found in the
protoplast (P) and mutanolysin extract. The flagellar cap
protein FliD, on the other hand, was largely found as expected
only in the protoplast cell fraction (Figure 2). Besides the
supernatant, CD630_28300 was detected in the total extract
fraction, but not in the surface fractions, suggesting that it is
released from the bacterium rather than surface-associated.
CD630_28300 is a putative zinc metallopeptidase
As our aim was to study previously uncharacterized proteins
expressed extracellularly by C. difficile, we examined further
the unknown hypothetical proteins detected in culture
supernatants by BLAST analyses (Table 1). Interestingly, we
found that a BlastP search of CD630_28300 against all the
proteins in the NCBI database revealed similarity to the lethal
factor (LF) of Bacillus anthracis. Alignment of CD630_28300 to
the C-terminal, catalytically active, anthrax toxin lethal factor
(ATLF) domain of anthrax lethal factor (LF) showed that the
two sequences share an amino acid identity of 22%, with
conservation of residues involved in proteolytic activity in LF
and other zinc proteases, including the HEXXH motif (Figure
3A) [38]. CD630_28300 was detected in both 630 and R20291
(named CDR20291_2721) culture media and is conserved
among the C. difficile genomes reported in the NCBI database
with an amino acid identity ranging from 98 to 100%.
CD630_28300 displays a zinc-dependent cleavage of
fibronectin and fibrinogen
In order to study the cation-binding ability and proteolytic
activity of CD630_28300, a tag-less recombinant protein was
produced in E. coli. The homogeneity of the purified protein
was checked by SDS-PAGE. The protein exhibited a single
band on SDS-PAGE with relative mobility consistent with its
expected molecular mass (Figure S2).
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The protein was incubated with EDTA with low pH to remove
any bound divalent cation and differential scanning fluorimetry
(DSF) analysis was performed to investigate its ability to bind
zinc and other divalent cations. DSF assay showed a shift in
melting temperature upon addition of Zn2+, Cu2+ or Ni2+,
indicating that the apo-protein is able to bind all these metals
(Figure S3), and that the binding to metals stabilizes the
protein. Binding to metals was also confirmed by NMR analysis
(data not shown).
To understand if the recombinant protein had proteolytic
activity, we tested it on casein and gelatin substrates by
zymography and FRET (fluorescence resonance energy
transfer), and on MAPKKide, a synthetic peptide containing a
cleavage site for anthrax lethal factor, by FRET. No activity was
detected in any of these assays (data not shown). These data
are in accordance with our observation that only few of the
residues important for substrate accommodation in the catalytic
pocket of LF [39] are conserved in CD630_28300 (Figure 3A),
and are suggestive of a proteolytic activity that is distinct with
respect to LF.
As other bacterial metalloproteases have been previously
reported to be able to degrade extracellular matrix components
[40], we examined if CD630_28300 could cleave extracellular
matrix (ECM) components in vitro. We tested collagen types I,
II, III, IV, V and VI, fibrinogen and fibronectin. While none of the
collagens were cleaved (data not shown), human plasma
fibronectin and fibrinogen were cleaved upon incubation with
CD630_28300 in vitro at 37°C (Figure 3B-E). The proteolytic
effect was time and concentration dependent, with minimal
activity observed at 1 h and complete cleavage observed after
6 h for fibrinogen (Figure 3D and 3E) and 24 h for fibronectin
(Figure 3B and C). While high Zmp1 concentrations
(3.85-7.7µM) were required for activity with fibronectin after 24
h, concentrations of 0. -1µM were sufficient for proteolytic
activity with fibrinogen after 6 h. For fibrinogen, the activity was
observed as a reduction in molecular weight of the band
corresponding to Bβ-chains (Figure 3D, E). Zmp1 activity on
both substrates was dependent on the presence of Zn2+ (Figure
3B and 3D). Also, upon testing CD630_28300 proteolytic
activity in the absence of metals or in the presence of Cu2+ or
Ni2+, we observed the highest activity in the presence of Zn2+, in
accordance with its zinc-binding function (Figure S4). These
data demonstrate that CD630_28300, which we have named
zinc metalloprotease 1 (Zmp1), is a novel C. difficile zinc-
dependent protease.
Table 1. General features of the hypothetical proteins found
in both 630 and R20291 supernatants.
Locus tag Length (aa)Conserved domains*
N-terminal signal
peptide**
CD630_05490 136 none yes
CD630_11560 360 Tranglutaminase-likesuperfamilya (1.13e-07) lipobox LxxC
CD630_21270 274 none yes
CD630_22510 118 none lipobox VxxC
CD630_24800 279 G5 domainb (4.72e-05) yes
CD630_28300 220 Anthrax lethal factor (4.0 e-48) yes
CD630_36690 191 GerMN domainc (1.86e-10) lipobox AxxC
Footnotes: *Conserved domains have been identified running BLAST against the
non-redundant GenBank protein database. In parentheses the E values of
corresponding alignments are reported.
**. The presence of the N-terminal signal peptide has been assessed with
PSORTb software (http://www.psort.org/psortb/).
a. Transglutaminases are a family of enzymes that catalyze protein crosslink
reaction by establishing epsilon-(gamma-glutamyl) lysine isopeptide bonds [62].
b. The G5 domain has been found in a wide range of extracellular proteins,
including M26 peptidases and proteins involved in metabolism of bacterial cell
walls [63].
c. This domain has been detected and characterized in the putative peptidoglycan
binding protein GerM of Bacillus subtilis [50].
doi: 10.1371/journal.pone.0081306.t001
Figure 2.  Cellular localization of C. difficile 630 proteins detected by LC-MS/MS.  Immunoblotting analysis of cell and
supernatant fractions prepared from exponential phase cultures with antisera generated against CD630_01830, CD630_23650,
CD630_02370 (FliD) and CD630_28300. Cell fractions: total extract (TE), protoplast (P), mutanolysin extract (ME), S-layer extract
(SL). Supernatant fractions: total supernatant (TS), supernatant after ultracentrifugation (US), ultracentrifugation pellet (UP). 10 or
50 ng of each recombinant protein (RP) was loaded as control.
doi: 10.1371/journal.pone.0081306.g002
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Figure 3.  Zmp1 is a zinc-dependent protease with fibrinogen- and fibronectin-cleaving activity.  (A) Zmp1 shares sequence
similarity with the C-terminal ATLF catalytic domain of anthrax lethal factor. Residues previously involved in the zinc proteolytic
activity (indicated in bold) are conserved. (B) Time-dependent proteolytic activity of recombinant Zmp1 on fibronectin. 1µM
fibronectin from human plasma was incubated for 24 h at 37°C with 7.7 µM Zmp1 in the presence of 0.5 mM ZnCl2. At 0, 1, 3, 6 and
24 h after incubation, 1 µg of fibronectin was analyzed by SDS-PAGE followed by Coomassie-blue staining. Integrity of fibronectin in
the absence of Zmp1 was verified after 24 h of incubation in the same conditions. (C) Concentration-dependent activity of Zmp1 on
fibronectin was observed after incubation of different concentrations of Zmp1 with 1 µM of fibronectin for 24 h at 37°C in the
presence of 0.5 mM ZnCl2. 1 µg of fibronectin was analyzed by SDS-PAGE and Coomassie-blue staining. (D) Time-dependent
proteolytic activity of recombinant Zmp1 on fibrinogen. 1 µM fibrinogen was incubated for 24 h at 37°C with 1 µM Zmp1 in the
presence of 0.5 mM ZnCl2. At 0, 1, 3, 6 and 24 h after incubation, 5 µg of fibrinogen was analyzed by SDS-PAGE followed by
Coomassie-blue staining. Integrity of fibrinogen in the absence of Zmp1 was verified after 24 h of incubation in the same conditions.
(E) Concentration-dependent activity of Zmp1 on fibrinogen was observed after incubation of different concentrations of Zmp1 with 1
µM of substrate for 6 h at 37°C in the presence of 0.5 mM ZnCl2. 5 µg of fibrinogen was analyzed by SDS-PAGE and Coomassie-
blue staining.
doi: 10.1371/journal.pone.0081306.g003
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The fibrinogen N-terminal sequence established by the
automated Edman degradation procedure was Ala-Pro-Pro-
Pro-Pro-Ile-Ser-Gly-Gly-Gly, suggesting that the cleavage
happens between Pro61 and Ala62 at the N-terminus of the β-
chain. The N-terminal sequencing of the tested fibronectin
fragments was unsuccessful, perhaps due to the presence of
multiple cleaved fragments in the bands sequenced and/or the
presence of pyroglutamic acid residues at the N-terminus
which block Edman degradation [41].
Residues E143 and H146 are important for Zmp1
catalytic activity
To further analyze the residues that are involved in Zmp1
catalytic activity, we generated mutants in the HEXXH motif,
which is considered a fingerprint for zinc metalloproteases.
This motif has been characterized in anthrax lethal factor as
well as in other toxins, such as the tetanus and botulinum
neurotoxins [42]. In this motif, the imidazole rings of the two
histidine residues are part of the first shell of zinc coordination,
while the glutamate carboxylate binds the water molecule
implicated in the hydrolytic reaction [43].
We generated two mutants of Zmp1, E143A and H146A, by
site-directed mutagenesis. The purity of mutant recombinant
proteins was checked by SDS-PAGE. Both mutants exhibited a
single band on SDS-PAGE with the same molecular weight as
the wild type protein (Figure S2).
Stability and zinc-binding ability of these mutants were
evaluated by differential scanning fluorimetry (DSF) and
nuclear magnetic resonance (NMR) analyses (Figure 4A and
4B). In the DSF assay, both Zmp1 mutants showed a melting
temperature comparable to the wild type, indicating that
mutations do not affect protein stability. The E143A mutant was
able to bind zinc, as demonstrated by an increase in melting
temperature observed upon addition of this metal. On the
contrary, in the H146A mutant, the ability to bind zinc was
completely lost (Figure 4A). NMR analysis showed that wild
type and E143A Zmp1 could be metallated by an excess of
ZnCl2 solution, while H146A was not able to bind zinc, in
agreement with DSF data (Figure 4B). Binding of Zn2+ was
confirmed by atomic absorption spectroscopy. During zinc
addition to the wild type and E143A proteins, the 1H-15N HSQC
spectra showed two sets of signals arising from the apo and
the zinc-bound forms, indicating that exchange between the
two forms is slow on the NMR time scale. The titration was
conducted until spectral changes were no longer observed.
1H-15N HSQC spectrum of zinc-bound wild type and E143A
showed well-dispersed resonances indicating that metal
binding does not affect the overall fold. These mutants also
showed highly reduced activity on fibronectin, as compared to
wild type Zmp1 (Figure 4C), indicating that residues E143 and
H146 are both important for catalytic activity. To rule out that
this residual activity was due to an E. coli contaminant
protease, an unrelated recombinant protein purified in a similar
manner was incubated with fibronectin, but no cleavage of
fibronectin was observed (Figure S5). Both mutant proteins
showed no activity on fibrinogen in the presence of zinc,
confirming that residues E143 and H146 are both important for
the catalytic activity (Figure 4D).
Zmp1 destabilizes the fibronectin network produced by
human fibroblasts
We examined if the ability to cleave fibronectin in vitro was
relevant also in a cell model resembling the ECM components
produced by host cells. We used a human fibroblast cell line
(IMR-90) producing a complex fiber organization mainly
composed of fibronectin and collagens. Upon incubation of the
cells with wild type Zmp1 we found that the discrete fibronectin
network observed in the untreated cells was destabilized
(Figure 5); particularly, we observed the appearance of
unstructured fibers of cellular fibronectin indicative of
proteolytic activity of the protein (inset in Figure 5A). This effect
is zinc-dependent since the fiber disorganization is maximized
by the addition of ZnCl2 in the culture, whereas a minor effect is
observed in the absence of the cation in the medium (data not
shown). E143A and H146A mutations in Zmp1 abrogate the
observed destabilization of the fibronectin network (Figure 5A).
Immunoblotting analysis of cell supernatants incubated with
wild type Zmp1, E143A or H146A mutants with anti-fibronectin
confirmed that the cells treated with the native Zmp1 show
degradation of fibronectin, while the cells treated with medium
(control) or with the E143A and H146A mutants show a
fibronectin band of the expected size (230-250kDa) (Figure
5B).
Discussion
Although extracellular proteins are known to mediate events
involved in the gut pathogenesis during clostridial infections
[13,44], not many cell surface or secreted proteins of the
nosocomial pathogen C. difficile have been identified or
functionally characterized. In a careful analysis of the culture
supernatants of clinically relevant strains of C. difficile, we
found that the exoproteome comprises largely of surface-
associated proteins. Further analysis of one of the hypothetical
proteins of unknown function that we detected in the
extracellular milieu revealed a new zinc-dependent
metalloprotease which is able to cleave fibronectin and
fibrinogen.
A recent proteomic analysis of culture supernatants from
clinical C. difficile isolates reported the presence of several
putative surface-associated proteins, however, along with the
presence of a large number of cytoplasmic proteins [20]. The
presence of cytoplasmic proteins, which is a common indicator
of lysis, is found in several proteomic studies examining the
exoproteomes and complicates the interpretation of the cellular
localization of proteins [17,18]. Our work suggests that the
proteins we detect in culture supernatants are indeed
extracellular, as the preparations we used almost completely
lacked proteins of predicted cytoplasmic origin. Among the
proteins we detect in supernatants, the Cwp84 cysteine
protease and SlpA, the precursor of the two major S-layer
proteins, have been well studied and previously reported to be
present in culture supernatants [31]. The largest known CWP,
CwpV, which promotes C. difficile aggregation, was also
detected [29]. Several proteins that we find, such as Cwp84,
SlpA, FliC, FliD, Cwp2, Cwp18, Cwp66, CD630_26720 and
CD630_08730, have been shown to be immunoreactive to
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Figure 4.  Impaired fibronectin and fibrinogen-cleaving activities of the E143A and H146A Zmp1 mutants.  (A) Differential
scanning fluorimetry of wild type, E143A and H146A recombinant proteins in the absence or presence of 1:16 Zn2+. The minimum of
the derivative is the melting temperature. Shifts in melting curves for the wild type and mutant proteins are indicated with arrows. (B)
NMR analysis of wild type, E143A and H146A. 1H15N HSQC spectrum of apo (black) and in the presence of zinc (red) of Zmp1 wild
type, H146A and E143A. (C) Decreased ability of E143A and H146A Zmp1 mutants to cleave fibronectin. 1 µM fibronectin from
human plasma was incubated for 24 h at 37°C with no Zmp1 (control) or with 7.7 µM of wild type (WT), E143A or H146A Zmp1 in
the presence of 0.5 mM ZnCl2. 1 µg of fibronectin was analyzed by SDS-PAGE and Coomassie-blue staining. (D) Inability of E143A
and H146A Zmp1 mutants to cleave fibrinogen. 1 µM fibrinogen was incubated for 24 h at 37°C with 1 µM of wild type (WT), E143A
or H146A Zmp1 in the presence of 0.5 mM ZnCl2. 1 µg of fibrinogen was analyzed by SDS-PAGE and Coomassie-blue staining.
doi: 10.1371/journal.pone.0081306.g004
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Figure 5.  Proteolytic activity of Zmp1 protein on native fibronectin produced by cultured human fibroblasts.  (A) IMR-90
human fibroblasts were incubated with 11.6 µM of wild type, E143A or H146A Zmp1 protein for 16 h as described in Methods.
Fibronectin was labeled using anti-fibronectin followed by Alexa568-conjugated secondary antibodies (red) and nuclei were stained
with DAPI (blue). Control cells were incubated with an equivalent volume of buffer for the same time period. Destabilization of
fibronectin was observed upon treatment of cells with Zmp1, as also highlighted in the inset. The images shown are representative
of 3 independent experiments. (B) Immunoblotting analysis of culture supernatants from IMR-90 cells treated with 11.6 µM of wild
type, E143A or H146A Zmp1 protein for 16 h. 100 µl undiluted supernatants from each well were probed with anti fibronectin.
doi: 10.1371/journal.pone.0081306.g005
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human sera [45,46]. In addition to known proteins, our analysis
reports many other uncharacterized CWPs, hydrolases,
transporters and hypothetical proteins. Further studies of these
proteins could provide insight into both bacterial physiology and
pathogenesis.
Surface proteins have been reported from culture
supernatants of other Gram-positive bacteria [47,48]. The
cleavage of surface proteins by proteases has been previously
proposed as a mechanism by which proteins are released from
the surface in bacteria such as Streptococcus pyogenes [49].
The mechanisms controlling the release of surface associated
proteins in C. difficile are at present unclear. C. difficile
encodes at least two cysteine proteases, Cwp84 and Cwp13,
which are involved in surface maturation [30,31]. A possibility is
that these, other reported or yet unidentified proteases are
involved in cleavage of some surface proteins of C. difficile.
Indeed, surface proteins may be released or shed into the
extracellular environment, perhaps as a result of abundant
expression on the surface. It does not appear to be induced by
our culture conditions (growth in minimal medium) in vitro, as
we see a predominance of surface-associated proteins also in
supernatants derived from bacterial growth in various rich
culture media tested (data not shown). Presence of surface-
associated proteins in the extracellular milieu may suggest that
in vivo, during infection, such proteins are not just associated to
the bacterial surface but may also act distally.
The global analysis of C. difficile supernatants resulted in the
identification of seven unknown hypothetical proteins. Based
on similarities to known domains or proteins, we find some
proteins that may be involved in clostridial pathogenesis. One
such protein, CD630_36690, contains a GerMN domain which
was previously associated with cell development proteins [50].
The Bacillus subtilis GerM protein, which contains a duplicated
GerMN domain, was shown to be important for both sporulation
and spore germination [51]. The other interesting protein was
CD630_28300, which had sequence similarity to the catalytic
domain of the Bacillus anthracis lethal factor, a well-
characterized zinc metalloprotease. We have named
CD630_28300 as Zmp1 and have characterized it further in our
study.
Zinc metalloproteases are secreted by a variety of bacterial
pathogens [40]. Many of these bacterial enzymes have been
shown to degrade extracellular matrix molecules such as
collagens, fibronectin and mucins. Examples include the
metalloproteases produced by Vibrio and Serratia species
[52,53]. Other zinc proteases, such as the clostridial
neurotoxins, proteolyse host proteins involved in
neuroexocytosis, affecting neurotransmission [54]. The anthrax
lethal factor, a zinc-metallopeptidase and major virulence factor
of B. anthracis, was demonstrated to enter cells and cleave the
mitogen activated protein kinase (MAPK) kinases [55]. Zmp1-
like proteins, bearing similarity to an ATLF-like domain, also
appear to be conserved in several bacterial species, as
revealed by BlastP analyses. These also include one of the
several zinc metalloproteases produced by the gut pathogen
Vibrio cholerae, mop, which is encoded in the Vibrio
pathogenicity island (VPI) and has been implicated in
pathogenesis [56].
Although several metalloproteases have been predicted from
the C. difficile genome sequence [28], none have been
characterized as yet. We describe for the first time a
metalloprotease, Zmp1, which demonstrates a zinc-dependent
activity in vitro. By selectively mutating residues that are in the
HEXXH motif, a conserved motif typical to zinc
metalloproteases and crucial for proteolytic activity [38], we
demonstrate that residues E143 and H146 are important for the
catalytic activity of Zmp1. NMR and DSF analyses show that
H146 is required for binding to Zn2+, while mutations in both
residues affect activity on plasma fibronectin and fibrinogen in
vitro. This is in accordance with the role previously attributed to
these residues in other zinc metalloproteases [38,53]. In
addition, our studies show that Zmp1 is active on fibrinogen
Bβ-chains and fibronectin, but not on other substrates such as
casein or different collagen types that were tested. Zmp1 is
clearly more efficient in cleaving fibrinogen as compared to
fibronectin in vitro, as indicated by the differences in kinetics
and enzyme to substrate ratios. A low fibronectin activity may
be due to the sub-optimal in vitro reaction conditions. As seen
by the decreased activity of mutant proteins on both fibrinogen
and fibronectin, the activity of Zmp1 is very specific.
Furthermore, we also find that Zmp1 cleaves at the N-terminus
of the Bbeta chain of fibrinogen.
Proteolytic enzymes are frequently involved in the bacterial
colonization process, contributing to nutrient acquisition,
degradation of host proteins or processing of bacterial proteins
involved in pathogenesis [57]. C. difficile strains were reported
to have proteolytic activity on substrates such as collagen,
casein and gelatin, although the enzymes were not identified
[58]. The cysteine protease Cwp84, the best-studied C. difficile
protease, cleaves SlpA, the precursor of high- and low-MW S-
layer proteins. Cwp84 was earlier reported to cleave ECM
proteins fibronectin, vitronectin and laminin [15]. We
demonstrate that recombinant Zmp1 can degrade fibronectin
on cultured human fibroblasts that produce a dense fibronectin
network. During pathogenesis of C. difficile, Zmp1 may aid the
bacterial colonization processes in the gut by degrading ECM
components associated with the gut epithelial cells. Several
pathogens including gut pathogens have been reported to
secrete both proteins involved in ECM adhesion and proteases
involved in ECM degradation [59]. C. difficile has been reported
to bind to ECM associated proteins such as collagen,
fibronectin and fibrinogen [60,61]. Proteases such as Zmp1 by
degrading the ECM components may contribute to invasion
and dissemination. Experiments examining C. difficile
interactions with eukaryotic cells would confirm the role of
Zmp1 in host cell modulation, however given the short life of
cells under anaerobic conditions, such experiments are
challenging. While Zmp1 demonstrates specific activity for
fibrinogen and fibronectin, it is possible that it has additional
ECM substrates especially in the context of gut infection.
Thus, employing proteomics, we identify new extracellular
factors that may be important for the pathogenesis of C.
difficile. Further examination of the mechanisms involved in the
release of surface-associated proteins into the extracellular
milieu could clarify how the clostridial cell surface is modulated
and how these proteins may interact with host cells.
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Supporting Information
Figure S1.  Proteins detected in C. difficile 630 and R20291
culture supernatants in individual experiments.
(TIF)
Figure S2.  SDS_PAGE analysis of the purified Zmp1 WT,
E143A and H146A. 2.5 or 12.5µg purified recombinant protein
were analyzed by SDS-PAGE followed by Coomassie-blue
staining.
(TIF)
Figure S3.  Zmp1 is able to bind divalent cations.
Differential scanning fluorimetry of Zmp1 recombinant protein
in the absence of divalent cations or in the presence of Zn2+,
Cu2+ or Ni2+.
(TIF)
Figure S4.  Zinc-dependent proteolytic activity of
recombinant Zmp1 on fibronectin. 1 µM fibronectin from
human plasma was incubated for 24 h at 37°C with 7.7 µM of
Zmp1 in the presence of 0.5 mM ZnCl2, NiCl2, CuCl2 or in the
absence of divalent cations. 1 µg of fibronectin was analyzed
by SDS-PAGE and silver staining.
(TIF)
Figure S5.  Proteolytic activity of recombinant Zmp1 is not
due to presence of contaminant E. coli proteases. 1 µM
fibronectin from human plasma was incubated for 24 h at 37°C
with 7.7 µM Zmp1 or 5.5 µM of an unrelated protein
(Staphylococcus aureus FhuD2) in the presence of 0.5 mM




We would like to thank Dr. Roberto Petracca and Dr. Stefano
Bonacci from Novartis vaccines for their help with generation of
DNA constructs for recombinant protein expression.
Author Contributions
Conceived and designed the experiments: VC MB MM RL FC
NN MS DS MU. Performed the experiments: VC MB MM RL JR
MU. Analyzed the data: VC MB MM RL JR FC NN MS DS MU.
Contributed reagents/materials/analysis tools: MB MM RL FC
MS. Wrote the manuscript: VC DS MU.
References
1. Rupnik M, Wilcox MH, Gerding DN (2009) Clostridium difficile infection:
new developments in epidemiology and pathogenesis. Nat Rev
Microbiol 7: 526-536. doi:10.1038/nrmicro2164. PubMed: 19528959.
2. Kuipers EJ, Surawicz CM (2008) Clostridium difficile infection. Lancet
371: 1486-1488. doi:10.1016/S0140-6736(08)60635-2. PubMed:
18456087.
3. Warny M, Pepin J, Fang A, Killgore G, Thompson A et al. (2005) Toxin
production by an emerging strain of Clostridium difficile associated with
outbreaks of severe disease in North America and Europe. Lancet 366:
1079-1084. doi:10.1016/S0140-6736(05)67420-X. PubMed: 16182895.
4. O'Connor JR, Johnson S, Gerding DN (2009) Clostridium difficile
infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology
136: 1913-1924. doi:10.1053/j.gastro.2009.02.073. PubMed:
19457419.
5. Surawicz CM, Alexander J (2011) Treatment of refractory and recurrent
Clostridium difficile infection. Nat Rev Gastroenterol Hepatol 8:
330-339. doi:10.1038/nrgastro.2011.59. PubMed: 21502971.
6. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A et al. (2010)
The role of toxin A and toxin B in Clostridium difficile infection. Nature
467: 711-713. doi:10.1038/nature09397. PubMed: 20844489.
7. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP et al.
(2009) Toxin B is essential for virulence of Clostridium difficile. Nature
458: 1176-1179. doi:10.1038/nature07822. PubMed: 19252482.
8. Voth DE, Ballard JD (2005) Clostridium difficile toxins: mechanism of
action and role in disease. Clin Microbiol Rev 18: 247-263. doi:10.1128/
CMR.18.2.247-263.2005. PubMed: 15831824.
9. Schwan C, Stecher B, Tzivelekidis T, van Ham M, Rohde M et al.
(2009) Clostridium difficile toxin CDT induces formation of microtubule-
based protrusions and increases adherence of bacteria. PLOS Pathog
5: e1000626. PubMed: 19834554.
10. Barketi-Klai A, Hoys S, Lambert-Bordes S, Collignon A, Kansau I
(2011) Role of fibronectin-binding protein A in Clostridium difficile
intestinal colonization. J Med Microbiol 60: 1155-1161. doi:10.1099/
jmm.0.029553-0. PubMed: 21349990.
11. Dingle TC, Mulvey GL, Armstrong GD (2011) Mutagenic analysis of the
Clostridium difficile flagellar proteins, FliC and FliD, and their
contribution to virulence in hamsters. Infect Immun 79: 4061-4067. doi:
10.1128/IAI.05305-11. PubMed: 21788384.
12. Tasteyre A, Barc MC, Collignon A, Boureau H, Karjalainen T (2001)
Role of FliC and FliD flagellar proteins of Clostridium difficile in
adherence and gut colonization. Infect Immun 69: 7937-7940. doi:
10.1128/IAI.69.12.7937-7940.2001. PubMed: 11705981.
13. Calabi E, Calabi F, Phillips AD, Fairweather NF (2002) Binding of
Clostridium difficile surface layer proteins to gastrointestinal tissues.
Infect Immun 70: 5770-5778. doi:10.1128/IAI.70.10.5770-5778.2002.
PubMed: 12228307.
14. Waligora AJ, Hennequin C, Mullany P, Bourlioux P, Collignon A et al.
(2001) Characterization of a cell surface protein of Clostridium difficile
with adhesive properties. Infect Immun 69: 2144-2153. doi:10.1128/IAI.
69.4.2144-2153.2001. PubMed: 11254569.
15. Janoir C, Péchiné S, Grosdidier C, Collignon A (2007) Cwp84, a
surface-associated protein of Clostridium difficile, is a cysteine protease
with degrading activity on extracellular matrix proteins. J Bacteriol 189:
7174-7180. doi:10.1128/JB.00578-07. PubMed: 17693508.
16. Miura M, Kato H, Matsushita O (2011) Identification of a novel virulence
factor in Clostridium difficile that modulates toxin sensitivity of cultured
epithelial cells. Infect Immun 79: 3810-3820. doi:10.1128/IAI.00051-11.
PubMed: 21746858.
17. Pacheco LG, Slade SE, Seyffert N, Santos AR, Castro TL et al. (2011)
A combined approach for comparative exoproteome analysis of
Corynebacterium pseudotuberculosis. BMC Microbiol 11: 12. doi:
10.1186/1471-2180-11-12. PubMed: 21241507.
18. Sengupta N, Alam SI, Kumar B, Kumar RB, Gautam V et al. (2010)
Comparative proteomic analysis of extracellular proteins of Clostridium
perfringens type A and type C strains. Infect Immun 78: 3957-3968. doi:
10.1128/IAI.00374-10. PubMed: 20605988.
19. Wright A, Wait R, Begum S, Crossett B, Nagy J et al. (2005) Proteomic
analysis of cell surface proteins from Clostridium difficile. Proteomics 5:
2443-2452. doi:10.1002/pmic.200401179. PubMed: 15887182.
20. Boetzkes A, Felkel KW, Zeiser J, Jochim N, Just I et al. (2012)
Secretome analysis of Clostridium difficile strains. Arch Microbiol 194:
675-687. doi:10.1007/s00203-012-0802-5. PubMed: 22398929.
21. Mukherjee K, Karlsson S, Burman LG, Akerlund T (2002) Proteins
released during high toxin production in Clostridium difficile.
Microbiology 148: 2245-2253. PubMed: 12101311.
22. Karasawa T, Ikoma S, Yamakawa K, Nakamura S (1995) A defined
growth medium for Clostridium difficile. Microbiology 141(Pt 2):
371-375. doi:10.1099/13500872-141-2-371.
23. Bensi G, Mora M, Tuscano G, Biagini M, Chiarot E et al. (2012) Multi
high-throughput approach for highly selective identification of vaccine
candidates: the Group A Streptococcus case. Mol Cell Proteomics 11:
015693
24. Calabi E, Ward S, Wren B, Paxton T, Panico M et al. (2001) Molecular
characterization of the surface layer proteins from Clostridium difficile.
A Zinc Metalloprotease Identified by Proteomics
PLOS ONE | www.plosone.org 13 November 2013 | Volume 8 | Issue 11 | e81306
Mol Microbiol 40: 1187-1199. doi:10.1046/j.1365-2958.2001.02461.x.
PubMed: 11401722.
25. Niesen FH, Berglund H, Vedadi M (2007) The use of differential
scanning fluorimetry to detect ligand interactions that promote protein
stability. Nat Protoc 2: 2212-2221. doi:10.1038/nprot.2007.321.
PubMed: 17853878.
26. Karjalainen T, Waligora-Dupriet AJ, Cerquetti M, Spigaglia P, Maggioni
A et al. (2001) Molecular and genomic analysis of genes encoding
surface-anchored proteins from Clostridium difficile. Infect Immun 69:
3442-3446. doi:10.1128/IAI.69.5.3442-3446.2001. PubMed: 11292772.
27. Schneewind O, Mihaylova-Petkov D, Model P (1993) Cell wall sorting
signals in surface proteins of gram-positive bacteria. EMBO J 12:
4803-4811. PubMed: 8223489.
28. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N et al.
(2006) The multidrug-resistant human pathogen Clostridium difficile has
a highly mobile, mosaic genome. Nat Genet 38: 779-786. doi:10.1038/
ng1830. PubMed: 16804543.
29. Reynolds CB, Emerson JE, de la Riva L, Fagan RP, Fairweather NF
(2011) The Clostridium difficile cell wall protein CwpV is antigenically
variable between strains, but exhibits conserved aggregation-promoting
function. PLOS Pathog 7: e1002024. PubMed: 21533071.
30. Kirby JM, Ahern H, Roberts AK, Kumar V, Freeman Z et al. (2009)
Cwp84, a surface-associated cysteine protease, plays a role in the
maturation of the surface layer of Clostridium difficile. J Biol Chem 284:
34666-34673. doi:10.1074/jbc.M109.051177. PubMed: 19808679.
31. de la Riva L, Willing SE, Tate EW, Fairweather NF (2011) Roles of
cysteine proteases Cwp84 and Cwp13 in biogenesis of the cell wall of
Clostridium difficile. J Bacteriol 193: 3276-3285. doi:10.1128/JB.
00248-11. PubMed: 21531808.
32. Fagan RP, Albesa-Jové D, Qazi O, Svergun DI, Brown KA et al. (2009)
Structural insights into the molecular organization of the S-layer from
Clostridium difficile. Mol Microbiol 71: 1308-1322. doi:10.1111/j.
1365-2958.2009.06603.x. PubMed: 19183279.
33. Monot M, Boursaux-Eude C, Thibonnier M, Vallenet D, Moszer I et al.
(2011) Reannotation of the genome sequence of Clostridium difficile
strain 630. J Med Microbiol 60: 1193-1199. doi:10.1099/jmm.
0.030452-0. PubMed: 21349987.
34. Dhalluin A, Bourgeois I, Pestel-Caron M, Camiade E, Raux G et al.
(2005) Acd, a peptidoglycan hydrolase of Clostridium difficile with N-
acetylglucosaminidase activity. Microbiology 151: 2343-2351. doi:
10.1099/mic.0.27878-0. PubMed: 16000724.
35. Tasteyre A, Barc MC, Karjalainen T, Dodson P, Hyde S et al. (2000) A
Clostridium difficile gene encoding flagellin. Microbiology 146(Pt 4):
957-966. PubMed: 10784054.
36. Rodríguez-Ortega MJ, Norais N, Bensi G, Liberatori S, Capo S et al.
(2006) Characterization and identification of vaccine candidate proteins
through analysis of the group A Streptococcus surface proteome. Nat
Biotechnol 24: 191-197. doi:10.1038/nbt1179. PubMed: 16415855.
37. Tasteyre A, Karjalainen T, Avesani V, Delmée M, Collignon A et al.
(2001) Molecular characterization of fliD gene encoding flagellar cap
and its expression among Clostridium difficile isolates from different
serogroups. J Clin Microbiol 39: 1178-1183. doi:10.1128/JCM.
39.3.1178-1183.2001. PubMed: 11230454.
38. Klimpel KR, Arora N, Leppla SH (1994) Anthrax toxin lethal factor
contains a zinc metalloprotease consensus sequence which is required
for lethal toxin activity. Mol Microbiol 13: 1093-1100. doi:10.1111/j.
1365-2958.1994.tb00500.x. PubMed: 7854123.
39. Dalkas GA, Chasapis CT, Gkazonis PV, Bentrop D, Spyroulias GA
(2010) Conformational dynamics of the anthrax lethal factor catalytic
center. Biochemistry 49: 10767-10769. doi:10.1021/bi1017792.
PubMed: 21121613.
40. Häse CC, Finkelstein RA (1993) Bacterial extracellular zinc-containing
metalloproteases. Microbiol Rev 57: 823-837. PubMed: 8302217.
41. Hoffmann BR, Annis DS, Mosher DF (2011) Reactivity of the N-terminal
region of fibronectin protein to transglutaminase 2 and factor XIIIA. J
Biol Chem 286: 32220-32230. doi:10.1074/jbc.M111.255562. PubMed:
21757696.
42. Hooper NM (1994) Families of zinc metalloproteases. FEBS Lett 354:
1-6. doi:10.1016/0014-5793(94)01079-X. PubMed: 7957888.
43. Tonello F, Montecucco C (2009) The anthrax lethal factor and its MAPK
kinase-specific metalloprotease activity. Mol Aspects Med 30: 431-438.
doi:10.1016/j.mam.2009.07.006. PubMed: 19665472.
44. Péchiné S, Janoir C, Boureau H, Gleizes A, Tsapis N et al. (2007)
Diminished intestinal colonization by Clostridium difficile and immune
response in mice after mucosal immunization with surface proteins of
Clostridium difficile. Vaccine 25: 3946-3954. doi:10.1016/j.vaccine.
2007.02.055. PubMed: 17433506.
45. Péchiné S, Gleizes A, Janoir C, Gorges-Kergot R, Barc MC et al.
(2005) Immunological properties of surface proteins of Clostridium
difficile. J Med Microbiol 54: 193-196. doi:10.1099/jmm.0.45800-0.
PubMed: 15673516.
46. Wright A, Drudy D, Kyne L, Brown K, Fairweather NF (2008)
Immunoreactive cell wall proteins of Clostridium difficile identified by
human sera. J Med Microbiol 57: 750-756. doi:10.1099/jmm.0.47532-0.
PubMed: 18480333.
47. Desvaux M, Dumas E, Chafsey I, Chambon C, Hébraud M (2010)
Comprehensive appraisal of the extracellular proteins from a
monoderm bacterium: theoretical and empirical exoproteomes of
Listeria monocytogenes EGD-e by secretomics. J Proteome Res 9:
5076-5092. doi:10.1021/pr1003642. PubMed: 20839850.
48. Ravipaty S, Reilly JP (2010) Comprehensive characterization of
methicillin-resistant Staphylococcus aureus subsp. aureus COL
secretome by two-dimensional liquid chromatography and mass
spectrometry. Mol Cell Proteomics 9: 1898-1919. doi:10.1074/
mcp.M900494-MCP200. PubMed: 20418541.
49. Nelson DC, Garbe J, Collin M (2011) Cysteine proteinase SpeB from
Streptococcus pyogenes - a potent modifier of immunologically
important host and bacterial proteins. Biol Chem 392: 1077-1088.
PubMed: 22050223.
50. Rigden DJ, Galperin MY (2008) Sequence analysis of GerM and
SpoVS, uncharacterized bacterial 'sporulation' proteins with widespread
phylogenetic distribution. Bioinformatics 24: 1793-1797. doi:10.1093/
bioinformatics/btn314. PubMed: 18562273.
51. Slynn GM, Sammons RL, Smith DA, Moir A, Corfe BM (1994)
Molecular genetical and phenotypical analysis of the gerM spore
germination gene of Bacillus subtilis. FEMS Microbiol Lett 121:
315-320. doi:10.1111/j.1574-6968.1994.tb07119.x. PubMed: 7926687.
52. Molla A, Tanase S, Hong YM, Maeda H (1988) Interdomain cleavage of
plasma fibronectin by zinc-metalloproteinase from Serratia
marcescens. Biochim Biophys Acta 955: 77-85. doi:
10.1016/0167-4838(88)90181-1. PubMed: 3289620.
53. Teo JW, Zhang LH, Poh CL (2003) Cloning and characterization of a
metalloprotease from Vibrio harveyi strain AP6. Gene 303: 147-156.
doi:10.1016/S0378-1119(02)01151-4. PubMed: 12559576.
54. Breidenbach MA, Brunger AT (2004) Substrate recognition strategy for
botulinum neurotoxin serotype A. Nature 432: 925-929. doi:10.1038/
nature03123. PubMed: 15592454.
55. Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR et al.
(1998) Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal
factor. Science 280: 734-737. doi:10.1126/science.280.5364.734.
PubMed: 9563949.
56. Zhang D, Xu Z, Sun W, Karaolis DK (2003) The vibrio pathogenicity
island-encoded mop protein modulates the pathogenesis and
reactogenicity of epidemic vibrio cholerae. Infect Immun 71: 510-515.
doi:10.1128/IAI.71.1.510-515.2003. PubMed: 12496202.
57. Maeda H, Yamamoto T (1996) Pathogenic mechanisms induced by
microbial proteases in microbial infections. Biol Chem Hoppe Seyler
377: 217-226. doi:10.1515/bchm3.1996.377.4.217. PubMed: 8737987.
58. Poilane I, Karjalainen T, Barc MC, Bourlioux P, Collignon A (1998)
Protease activity of Clostridium difficile strains. Can J Microbiol 44:
157-161. doi:10.1139/cjm-44-2-157. PubMed: 9543717.
59. Singh B, Fleury C, Jalalvand F, Riesbeck K (2012) Human pathogens
utilize host extracellular matrix proteins laminin and collagen for
adhesion and invasion of the host. FEMS Microbiol Rev 36: 1122-1180.
doi:10.1111/j.1574-6976.2012.00340.x. PubMed: 22537156.
60. Cerquetti M, Serafino A, Sebastianelli A, Mastrantonio P (2002) Binding
of Clostridium difficile to Caco-2 epithelial cell line and to extracellular
matrix proteins. FEMS Immunol Med Microbiol 32: 211-218. doi:
10.1111/j.1574-695X.2002.tb00556.x. PubMed: 11934566.
61. Tulli L, Marchi S, Petracca R, Shaw HA, Fairweather NF et al. (2013)
CbpA: a novel surface exposed adhesin of Clostridium difficile targeting
human collagen. Cell Microbiol 15: 1674–87. PubMed: 23517059.
62. Yokoyama K, Nio N, Kikuchi Y (2004) Properties and applications of
microbial transglutaminase. Appl Microbiol Biotechnol 64: 447-454. doi:
10.1007/s00253-003-1539-5. PubMed: 14740191.
63. Bateman A, Holden MT, Yeats C (2005) The G5 domain: a potential N-
acetylglucosamine recognition domain involved in biofilm formation.
Bioinformatics 21: 1301-1303. doi:10.1093/bioinformatics/bti206.
PubMed: 15598841.
A Zinc Metalloprotease Identified by Proteomics
PLOS ONE | www.plosone.org 14 November 2013 | Volume 8 | Issue 11 | e81306
